Cargando...

Preclinical Studies of Chemotherapy Using Histone Deacetylase Inhibitors in Endometrial Cancer

Because epigenetic alterations are believed to be involved in the repression of tumor suppressor genes and promotion of tumorigenesis in endometrial cancers, novel compounds endowed with a histone deacetylase (HDAC) inhibitory activity are an attractive therapeutic approach. In this review, we discu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Takai, Noriyuki, Narahara, Hisashi
Formato: Artigo
Lenguaje:Inglês
Publicado: Hindawi Publishing Corporation 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2821626/
https://ncbi.nlm.nih.gov/pubmed/20169171
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/923824
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!